1 / 6

Point of Care (PoC) molecular diagnostics market report for 2027 – Companies, ap

This Point of Care (PoC) molecular diagnostics market report is an exhaustive research on companies active in Point of Care (PoC) molecular diagnostics sector, its applications, products, end-users, trends and predictions on how the market will grow in coming years.

Kiransable07
Download Presentation

Point of Care (PoC) molecular diagnostics market report for 2027 – Companies, ap

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care (PoC) molecular diagnostics market trends research and projections for 2020- 2027 • A research study conducted by Global Market Insights, Inc., suggests that point of Care (PoC) molecular diagnostics market is likely to exceed the $5 Billion mark by 2027, in terms of revenue. Rising incidence of multiple infectious diseases like COVID-19 and others are expected to offer multiple business opportunities for PoC molecular diagnostics device manufacturers. The COVID-19 pandemic has shifted the focus on the substantial need for OTC (over-the-counter) and (PoC) point-of-care testing to detect viruses other disease-causing agents. • The point of care (PoC) molecular diagnostic market is poised to showcase sturdy growth owing to escalating prevalence of infectious diseases in emerged and emerging nations. Rising incidence of multiple infectious diseases like COVID-19 and others are expected to offer multiple business opportunities for PoC molecular diagnostics device manufacturers. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Technological innovations in PoC tests and multiple collaborations may expand the development of point of care (POC) molecular diagnostics systems. • Funding directed towards supporting research & development activities in the healthcare sector, especially since the pandemic, could support this development. The European Regional Development Fund and Archimedes supported and gave funding of over USD 2.5 million to Self-diagnostics and the University of Tartu. These organizations mainly focus on evolving DNA polymerase which is inhibitor-tolerant and is used in isothermal amplification directly from the unprocessed samples for use in infectious disease POC diagnostics. s • The need for portable diagnostics devices is also gaining momentum lately. In 2021, comprehensive molecular diagnostic system developer, MatMaCorp (Materials and Machines Corp. launched MYRTA™ (MY Real-Time Analyzer), its new hand-held device for conducting PCR (polymerase chain reaction) amplification and real-time fluorescent detection and for providing portable, PCR-based PoC and OTC molecular diagnostic solutions. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Request for a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2210 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. Regional Analysis • Region-wise, the Asia Pacific point of care (PoC) molecular diagnostics market is projected to witness lucrative growth owing to rising burden of infections and chronic conditions including cancer. Companies present in the region are broadening their geographic presence in untapped markets of Asia Pacific. Increasing number of geriatric population that is vulnerable to a wide range of diseases in the region could boost the requirement for better PoC diagnostics systems. As per a report published by Global Market Insights, the Asia Pacific point of care molecular diagnostics market is projected to foresee a 7.2% CAGR by 2027. • Competitive Analysis • Some other key players operating in the point of care molecular diagnostics industry are Abbott Laboratories, Roche Diagnostics, BioMérieux SA, Cepheid (Danaher Corporation), Bio-Rad Laboratories, among other industry players. Manufactures are stressing on commercializing new tests for rapid detection of a varied range of infectious diseases, including COVID-19. In Feb 2021, Mesa Biotech was acquired by Thermo Fisher Scientific Inc. to expand the benefits of molecular diagnostics at point of care. Request for Customization @ https://www.gminsights.com/roc/2210 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Latest Research Report On point of Care (PoC) molecular diagnostics Market @ https://www.gminsights.com/industry-analysis/point-of-care-poc-molecular-diagnostics-market Request for sample of this research report@ https://www.gminsights.com/request-sample/detail/2210 Request for customization: https://www.gminsights.com/roc/2210 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com

More Related